Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?

Mechanisms of Ageing and Development

Volumn 126, Issue 2, 2005, Pages 305-307

  Laron, Zvi ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Ames mice; Growth hormone deficiency; IGF I deficiency; Laron mice; Laron syndrome; Longevity

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; GENE DELETION; GENE MUTATION; GROWTH HORMONE DEFICIENCY; INSULIN RESISTANCE; LARON SYNDROME; LIFESPAN; LONGEVITY; NONHUMAN; OBESITY; OSTEOPENIA; PRIORITY JOURNAL; WRINKLE;

AGED; AGED, 80 AND OVER; AGING; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GROWTH HORMONE; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; LONGEVITY; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTATION; TIME FACTORS;

ANIMALIA;

EID: 11044228316     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2004.08.022     Document Type: Conference Paper

References (26)

1. E. Arvat, F. Broglio, and E. Ghigo Insulin-like growth factor I. Implications in aging Drugs Aging 16 2000 29 40
2. A. Bartke Growth hormone and aging Endocrine 8 1998 103 108
3. A. Bartke Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size S. Hekimi Results and Problems in Cell Differentiation. The Molecular Genetics of Aging vol. 29 2000 Springer Verlag Berlin-Heidelberg 181 202
4. A. Bartke Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice Neuroendocrinology 78 2003 210 216
5. P.V. Carroll, E.R. Christ, the members of Growth Hormone Research Society Scientific Committee:, B.A. Bengtsson, L. Carlsson, J.S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, P.H. Sonksen, T. Tanaka, and M. Thorner Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review J. Clin. Endocrinol. Metab. 83 1998 382 395
6. K.T. Coschigano, D. Clemmons, L.L. Bellush, and J.J. Kopchick Assessment of growth parameters and lifespan of GHR/GP gene-disrupted mice Endocrinology 141 2000 2608 2613
7. I. Gil-Ad, R. Gurewitz, O. Marcovici, J. Rosenfeld, and Z. Laron Effect of aging on human plasma growth hormone response to clonidine Mech. Ageing Dev. 27 1984 97 100
8. P.J. Godowski, D.W. Leung, L.R. Meacham, J.P. Galgagni, R. Hellmiss, R. Keret, P.S. Rotwein, J.S. Parks, Z. Laron, and W.I. Wood Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron type dwarfism Proc. Natl. Acad. Sci. U.S.A. 86 1989 8083 8087
9. D.C. Groesbeck, A.F. Parlow, and W.G. Daughaday Stimulation of supernormal growth in prepubertal adult plateaned and hypophysectomized female rats by large doses of rat growth hormone: physiological effects and adverse consequences Endocrinology 120 1987 1963 1975
10. M. Holzenberger, J. Dupont, B. Ducos, P. Leneuve, A. Geloen, P.C. Evens, P. Cervera, and Y. Le Bouc IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice Nature 421 2003 182 186
11. C. Krzisnik, Z. Kolacio, T. Battelino, M. Brown, J.S. Parks, and Z. Laron The 'Little People' of the island of Krk - revisited J. Endocrine Genet. 1 1999 9 19
12. Z. Laron Effects of growth hormone and insulin-like growth factor-I Deficiency on ageing and longevity J. Goode Endocrine Facets of Ageing. Novartis Foundation Symposium No. 242 2002 John Wiley & Sons Chichester 125 142
13. Z. Laron Insulin-like growth factor 1 (IGF-1): a growth hormone J. Clin. Pathol: Mol. Pathol. 54 2002 311 316
14. Z. Laron Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003 J. Clin. Endocrinol. Metab. 89 2004 1031 1044
15. Z. Laron, A. Pertzelan, and S. Mannheimer Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr. J. Med. Sci. 2 1966 152 155
16. Z. Laron, A. Pertzelan, and M. Karp Pituitary dwarfism with high serum levels of growth hormone Isr. J. Med. Sci. 4 1968 883 894
17. T. Merimee, and Z. Laron Growth Hormone, IGF-I and Growth: new views of old concepts T. Merimee Z. Laron Modern Endocrinology and Diabetes vol. 4 1996 Freund Publishing House Ltd. Tel Aviv, London
18. M. Niwa, Y. Sato, Y. Saito, F. Uchiyama, H. Ono, M. Yamashita, T. Kitaguchi, Y. Shiga, J. Notani, H. Yamada, Y. Ishii, I. Ueda, and Y. Takagi Chemical synthesis, cloning and expression of genes for human somatomedin C (insulin-like growth factor I) and 59Val somatomedin C Ann. N. Y. Acad. Sci. 469 1986 31 52
19. T. Rosen, and B-A. Bengtsson Premature mortality due to cardiovascular disease in hypopituitarism Lancet 336 1990 285 288
20. T. Rosen, S. Eden, G. Larson, L. Wilhelmsen, and B-A. Bengtsson Cardiovascular risk factors in adult patients with growth hormone deficiency Acta Endocrinol. 129 1993 195 200
21. A.L. Rosenbloom, J. Guevara-Aguirre, R.G. Rosenfeld, and U. Francke Growth hormone receptor deficiency in Ecuador J. Clin. Endocrinol. Metab. 84 1999 4436 4443
22. D. Rudman, A.G. Feller, H.S. Nagraj, G.A. Gergans, P.Y. Lalitha, A.F. Goldberg, R.A. Schlenker, L. Cohn, I.W. Rudman, and D.E. Marrson Effects of human growth hormone in men over 60 years old N. Engl. J. Med. 323 1990 1 6
23. R. Schaible, and J.W. Gower A new dwarf mouse Genetics 46 1961 896
24. M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O'Connell, I. Gukovsky, C. Carriere, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.F. Beamer, and M.G. Rosenfeld Pituitary lineage determination by the prophet of Pit-1 homeodomain factor defective in Ames dwarfism Nature 384 1996 327 333
25. J.W. Tomlison, N. Holden, R.K. Hills, K. Wheatley, R.N. Clayton, A.s. Bates, M.C. Sheppard, P.M. Stewart and the West Midlands Prospecltive Hypopituitary Study Group Association between premature mortality and hypopituitarism Lancet 357 2001 425 431
26. Y. Zhou, B.C. Xu, H.G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigano, T.E. Wagner, G. Baumann, and J.J. Kopchick A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) Proc. Natl. Acad. Sci. U.S.A. 94 1997 13215 13220